VGK vs XLV
Vanguard FTSE Europe ETF vs Health Care Select Sector SPDR Fund
- • VGK has the lower expense ratio at 0.06% vs 0.08% for XLV.
- • VGK pays a higher dividend yield (2.95%).
Side-by-side metrics
| Metric | VGK | XLV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.06% | 0.08% |
Dividend yield Trailing 12-month yield. | 2.95% | 1.38% |
AUM Assets under management — bigger funds are typically more liquid. | $37.08B | $49.10B |
YTD return | 9.90% | 23.16% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.88 | 0.41 |
P/E ratio | 17.79 | 30.63 |
Last price | $89.42 | $187.94 |
Inception | — | — |
Issuer | Vanguard | State Street |
VGK top holdings
| ASML.AS | ASML Holding NV | 4.47% |
| HSBA.L | HSBC Holdings PLC | 2.19% |
| ROP.SW | Roche Holding AG Ordinary Shares new | 1.89% |
| SHEL.L | Shell PLC | 1.79% |
| NOVN.SW | Novartis AG Registered Shares | 1.72% |
| AZN.L | AstraZeneca PLC | 1.57% |
| NESN.SW | Nestle SA | 1.51% |
| SIE.DE | Siemens AG | 1.45% |
| SAP.DE | SAP SE | 1.32% |
| SAN.MC | Banco Santander SA | 1.29% |
XLV top holdings
| LLY | Eli Lilly and Co | 16.88% |
| JNJ | Johnson & Johnson | 9.80% |
| ABBV | AbbVie Inc | 7.76% |
| MRK | Merck & Co Inc | 5.49% |
| UNH | UnitedHealth Group Inc | 5.44% |
| TMO | Thermo Fisher Scientific Inc | 3.84% |
| AMGN | Amgen Inc | 3.75% |
| GILD | Gilead Sciences Inc | 3.15% |
| ABT | Abbott Laboratories | 2.74% |
| PFE | Pfizer Inc | 2.59% |
About VGK
VGK (Vanguard FTSE Europe ETF) is European developed-market equities. Managed by Vanguard, the fund carries $37.1B in assets under management, an expense ratio of 0.06%, a dividend yield of 2.95%. Its largest holding is ASML Holding NV (ASML.AS), which represents 4.5% of the portfolio. Real Estate is the fund's largest sector exposure at 1.4%.
About XLV
XLV (Health Care Select Sector SPDR Fund) is S&P 500 health care sector. Managed by State Street, the fund carries $49.1B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.38%. Its largest holding is Eli Lilly and Co (LLY), which represents 16.9% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.